...
首页> 外文期刊>Current drug targets-The International journal for timely in-depth reviews on drug targets >Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.
【24h】

Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.

机译:血清素2受体激动剂作为新型的眼压降压药及其作用的细胞和分子机制。

获取原文
获取原文并翻译 | 示例
           

摘要

The eye is innervated by numerous serotonergic nerves and serotonin (5-hydroxytryptamine; 5HT) is present in the aqueous humor of animal and human eyes. In an effort to delineate the role of the serotonergic system in modulating intraocular pressure (IOP) within the anterior segment of the eye, extensive topical ocular dosing studies were conducted with a variety of 5HT ligands and in various animal species. Even though certain 5HT(1A) agonists decreased IOP in rabbits, these compounds failed to affect IOP in normotensive or ocular hypertensive monkey eyes. In contrast, while 5HT(2) agonists induced significant IOP reductions in normotensive rat eyes and in eyes of ocular hypertensive Cynomolgus monkeys, these agents were inactive in ocular normotensive cats and rabbits. Additional studies indicated a strong involvement of 5HT(2A) receptors in mediating IOP-lowering in conscious ocular hypertensive Cynomolgus monkeys. As a result of further structure-activity investigations, AL-34662, a selective 5HT(2) agonist (relative to other 5HT receptor types and sub-types) with high affinity, potency and efficacy at 5HT(2A), 5HT(2B) and 5HT(2C) receptors was discovered that efficaciously lowered IOP in the monkey model of ocular hypertension (33 +/- 3 % reduction out to 6 hrs post with a 300 microg topical ocular dose). Due to unavailability of monkey ocular cells, extensive in vitro studies were conducted using relevant human ocular cells in order to correlate with and support the in vivo observations in the monkeys. RT-PCR and in situ hybridization studies revealed the presence of mRNAs for 5HT(2A-C) receptor subtypes in human ocular tissues involved in IOP modulation. The relative distribution and density of these mRNAs were as follows: ciliary body (CB) (5HT(2A) > 5HT(2B) > 5HT(2C)), ciliary epithelium (CE) (5HT(2A) > 5HT(2B) = 5HT(2C)) and trabecular meshwork (TM) (5HT(2A)= 5HT(2B) 5HT(2C)). Furthermore, quantitative autoradiography revealed a relatively high specific binding of [(3)H]-5HT and [(3)H]-ketanserin to 5HT(2) receptors in human CE and longitudinal ciliary muscle (CM). Second messenger studies revealed the presence of phospholipase C-coupled 5HT(2A) receptors in h-CM and h-TM cells where they stimulated phosphoinositide (PI) hydrolysis and mobilized intracellular Ca(2+) when challenged with a variety of 5HT(2A-C) receptor agonists (e.g. alpha-methyl-5HT, (R)-DOI, alpha-methyl-5HT, BW-723C86, MK-212, mCPP, cabergoline, AL-34662). These functional responses were blocked by selective 5HT(2) receptor antagonists with the 5HT(2A) antagonist, M-100970, exhibiting the highest potency. Thus, functional 5HT(2A) receptors are present in human ocular cells involved in IOP reduction and this correlates with the ability of 5HT(2A) agonists to lower IOP in Cynomolgus monkeys, a surrogate for human subjects.
机译:眼睛被众多血清素能神经支配,动物和人眼的房水中都存在5-羟色胺(5-羟色胺; 5HT)。为了描述5-羟色胺能系统在调节眼前段内眼内压(IOP)中的作用,对多种5HT配体和各种动物进行了广泛的局部眼用药研究。即使某些5HT(1A)激动剂可降低兔子的IOP,但这些化合物仍无法影响正常血压或高眼压猴眼的IOP。相比之下,虽然5HT(2)激动剂在血压正常的大鼠眼睛和眼高压食蟹猕猴的眼睛中显着降低了IOP,但这些试剂在血压正常的猫和兔子中不起作用。其他研究表明5HT(2A)受体在介导有意识的眼高压食蟹猕猴的IOP降低中起着重要作用。作为进一步的结构活性研究的结果,AL-34662是一种选择性5HT(2)激动剂(相对于其他5HT受体类型和亚型),对5HT(2A),5HT(2B)具有高亲和力,效力和功效发现5HT(2C)和5HT(2C)受体可有效降低高眼压猴子模型中的IOP(使用300μg局部眼用药后6小时内,眼压降低33 +/- 3%)。由于无法获得猴眼细胞,因此使用相关的人眼细胞进行了广泛的体外研究,以便与猴的体内观察结果相关并提供支持。 RT-PCR和原位杂交研究揭示了参与IOP调节的人眼组织中5HT(2A-C)受体亚型的mRNA的存在。这些mRNA的相对分布和密度如下:睫状体(CB)(5HT(2A)> 5HT(2B)> 5HT(2C)),睫状上皮(CE)(5HT(2A)> 5HT(2B)= 5HT(2C))和小梁网(TM)(5HT(2A)= 5HT(2B) 5HT(2C))。此外,定量放射自显影显示[(3)H] -5HT和[(3)H]-酮色林与人类CE和纵向睫状肌(CM)中的5HT(2)受体相对较高的特异性结合。第二个信使研究揭示了在h-CM和h-TM细胞中存在磷脂酶C偶联的5HT(2A)受体,它们在受到多种5HT(2A)攻击时会刺激磷酸肌醇(PI)水解并动员细胞内Ca(2+)。 -C)受体激动剂(例如α-甲基-5HT,(R)-DOI,α-甲基-5HT,BW-723C86,MK-212,mCPP,卡麦角林,AL-34662)。这些功能性反应被选择性5HT(2)受体拮抗剂与5HT(2A)拮抗剂M-100970阻断,表现出最高的效力。因此,功能性5HT(2A)受体存在于与IOP降低有关的人眼细胞中,这与5HT(2A)激动剂降低食蟹猴(人类对象的替代品)降低IOP的能力有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号